Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
Source: briefingwire.com
Stay updated with breaking news from Builder Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round
HONG KONG, Oct 20, 2022 - (ACN Newswire) - VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion